Renin Inhibitor Market Analysis

The renin inhibitor market is segmented by product type & by application, out of which, the age above 66 segment of the application sector is anticipated to hold leading shares in the market on account of rising cardiovascular diseases and hypertension cases among this segment. According to the National Centre for Health Statistics. From 2015 to 2016, the prevalence of hypertension was 29.0% and increased with age: age group 18–39, 7.5%; 40–59, 33.2%; and 60 and over, 63.1%. On the contrary, 300mg/tablet segment of the product type sector is estimated to witness modest growth over the forecast period owing to the treatment of high blood pressure by relaxing blood vessels for a better circulation of the blood.

Our in-depth analysis of the global market includes the following segments: